Nevertheless, BRCA1 carriers were more likely to be triple negative breast cancer compared to BRCA2 carriers (p=0.002) and BRCA2 carriers were more likely to be luminal B breast cancer tumors (p=0.000078). The gene discussed is BRCA2; the disease is breast carcinoma.